Quality Improvement, Interventional, Open-Ended
Bioidentical Hormone Replacement Therapy (“BHRT”) is used to help treat female hormonal conditions. BHRT products are prescribed by clinicians and prepared by compounding pharmacies. This Circle captures symptoms and health-related quality-of-life data from pre- and post-administration of BHRT for 18 months. Outcome measures include the Cervantes Short-Form Scale and the Heavy Menstrual Bleeding-Visual Analog Scale. Aggregated Circle datasets will provide clinically significant evidence relating to safety and efficacy of BHRT for female patients.
Cervantes Short-Form Scale; Heavy Menstrual Bleeding-Visual Analog Scale
Clinically significant reduction in scores collected from the Cervantes Short-Form Scale at 6-months post-treatment.
Grant Pagdin, MD. Canadian board-certified in Family Medicine, American Academy of Anti-Aging and Regenerative Medicine (ABAARM). Fellowship in Family Medicine (FCFP). Fellowship in Stem Cell Medicine. Fellow with the Interventional Orthobiologics Foundation.
Endocrinologists, family practice and other primary care physicians, compounding pharmacies, obstetricians- gynecologists, advanced practice nurses and physicians assistants.
Collaboration with nationally recognized musculoskeletal physicians. Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of musculoskeletal indications. Drive superior patient education and engagement. Legal/regulatory compliance. Support payer negotiations.